Potent and selective cathepsin K inhibitors

被引：13
|
作者：
Shinozuka, Tsuyoshi
Shimada, Kousei
Matsui, Satoshi
Yamane, Takahiro
Ama, Mayumi
Fukuda, Takeshi
Taki, Motohiko
Takeda, Yuko
Otsuka, Eri
Yamato, Michiko
Mochizuki, Shin-ichi
Ohhata, Keiko
Naito, Satoru
机构：
[1] Sankyo Co Ltd, Med Chem Res Labs, Shinagawa Ku, Tokyo 1408710, Japan
[2] Sankyo Co Ltd, Lead Discovery Res Labs, Shinagawa Ku, Tokyo 1408710, Japan
[3] Sankyo Co Ltd, Biol Res Labs, Shinagawa Ku, Tokyo 1408710, Japan
来源：
BIOORGANIC & MEDICINAL CHEMISTRY | 2006年 / 14卷 / 20期
关键词：
cathepsin K; inhibitor; SAR study; OVX rat assay;
D O I：
10.1016/j.bmc.2006.06.032
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
A novel series of cathepsin K inhibitors derived from Novartis compound I is described. Optimization of the P1, P3, and P1' units led to the identification of 4-aminophenoxyacetic acid 24b with an IC50 value of 4.8 nM, which possessed an excellent selectivity over other human cathepsins and good pharmacokinetic (PK) properties. Oral administration of compound 24b to ovariectomized (OVX) rats showed a trend toward an improvement of bone mineral density (BMD) in the femur bone. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码：6789 / 6806
页数：18
相关论文
共 50 条
  • [1] Thiosemicarbazones as potent and selective cathepsin K inhibitors
    Chavarria, Gustavo E.
    Devanna, Kishore K. Gaddale
    Jones, Lindsay M.
    MacDonough, Matthew T.
    Yoo, Grace K.
    Locke, Ashleigh
    Deliz, Rafael
    Chaplin, David J.
    Siim, Bronwyn G.
    Chen, Shen-En
    Pinney, Kevin G.
    Trawick, Mary L.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 241
  • [2] Structure and design of potent and selective cathepsin K inhibitors
    Yamashita, DS
    Smith, WW
    Zhao, BG
    Janson, CA
    Tomaszek, TA
    Bossard, MJ
    Levy, MA
    Oh, HJ
    Carr, TJ
    Thompson, SK
    Ijames, CF
    Carr, SA
    McQueney, M
    DAlessio, KJ
    Amegadzie, BY
    Hanning, CR
    AbdelMeguid, S
    DesJarlais, RL
    Gleason, JG
    Veber, DF
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1997, 119 (46) : 11351 - 11352
  • [3] Design of potent, selective, and orally bioavailable inhibitors of cysteine protease cathepsin K
    Tavares, FX
    Boncek, V
    Deaton, DN
    Hassell, AM
    Long, ST
    Miller, AB
    Payne, AA
    Miller, LR
    Shewchuk, LM
    Wells-Knecht, K
    Willard, DH
    Wright, LL
    Zhou, HQ
    JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (03) : 588 - 599
  • [4] Potent and selective ketoamide-based inhibitors of cysteine protease, cathepsin K
    Tavares, FX
    Deaton, DN
    Miller, AB
    Miller, LR
    Wright, LL
    Zhou, HQ
    JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (21) : 5049 - 5056
  • [5] Design of potent and selective human cathepsin K inhibitors that span the active site
    Thompson, SK
    Halbert, SM
    Bossard, MJ
    Tomaszek, TA
    Levy, MA
    Zhao, BG
    Smith, WW
    Abdel-Meguid, SS
    Janson, CA
    D'Alessio, KJ
    McQueney, MS
    Amegadzie, BY
    Hanning, CR
    DesJarlais, RL
    Briand, J
    Sarkar, SK
    Huddleston, MJ
    Ijames, CF
    Carr, SA
    Garnes, KT
    Shu, A
    Heys, JR
    Bradbeer, J
    Zembryki, D
    Lee-Rykaczewski, L
    James, IE
    Lark, MW
    Drake, FH
    Gowen, M
    Gleason, JG
    Veber, DF
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (26) : 14249 - 14254
  • [6] Design of potent and selective cathepsin K inhibitors which span the active site.
    Thompson, SK
    Halbert, SM
    Michaud, E
    Bossard, MJ
    Tomaszek, TA
    Levy, MA
    Meek, TD
    Zhao, B
    Smith, WW
    Janson, CA
    McQueney, MS
    AbdelMeguid, SS
    Briand, J
    Sarkar, SK
    Huddleston, MJ
    Ijames, CF
    Carr, SA
    DesJarlais, RL
    Shu, A
    Garnes, K
    Heys, JR
    Zembryki, D
    LeeRykaczewski, LV
    James, IE
    Lark, M
    Bradbeer, JN
    Drake, FH
    Gowen, M
    Veber, DF
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 214 : 279 - MEDI
  • [7] Investigation of ketone warheads as alternatives to the nitrile for preparation of potent and selective cathepsin K inhibitors
    Boyd, Michael J.
    Crane, Sheldon N.
    Robichaud, Joel
    Scheigetz, John
    Black, W. Cameron
    Chauret, Nathalie
    Wang, Qingping
    Masse, Frederic
    Oballa, Renata M.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (03) : 675 - 679
  • [8] The identification of potent, selective, and bioavailable cathepsin S inhibitors
    Gauthier, Jacques Yves
    Black, W. Cameron
    Courchesne, Isabelle
    Cromlish, Wanda
    Desmarais, Sylvie
    Houle, Robert
    Lamotagne, Sonia
    Li, Chun Sing
    Masse, Frederic
    Mckay, Daniel J.
    Ouellet, Marc
    Robichaud, Joel
    Truchon, Jean-Francois
    Truong, Vouy-Linh
    Wang, Qingping
    Percival, M. David
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (17) : 4929 - 4933
  • [9] Potent dipeptidylketone inhibitors of the cysteine protease cathepsin K
    Marquis, RW
    Ru, Y
    Yamashita, DS
    Oh, HJ
    Yen, J
    Thompson, SK
    Carr, TJ
    Levy, MA
    Tomaszek, TA
    Ijames, CF
    Smith, WW
    Zhao, BG
    Janson, CA
    Abdel-Meguid, SS
    D'Alessio, KJ
    McQueney, MS
    Veber, DF
    BIOORGANIC & MEDICINAL CHEMISTRY, 1999, 7 (04) : 581 - 588
  • [10] Design and synthesis of potent and selective inhibitors of the osteoclast-specific cysteine protease, cathepsin K
    Veber, DF
    Marquis, RW
    Ru, Y
    Yamashita, DS
    Oh, HJ
    Thompson, SK
    Halbert, SM
    Carr, TJ
    Gleason, JG
    Tomaszek, TA
    Levy, MA
    Bossard, M
    Tew, DG
    James, IE
    Briand, J
    Carr, SA
    Zymbryki, D
    Lee-Rykaczewski, L
    Desjarlais, RL
    McQueney, MS
    D'Alessio, KJ
    Zhao, B
    Janson, CA
    Abdel-Meguid, SS
    Smith, WW
    PEPTIDE SCIENCE - PRESENT AND FUTURE, 1999, : 628 - 630
12345